- Home
- RVNC vs XFLT Comparison
RVNC vs XFLT Comparison
Compare RVNC & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- XFLT
- Stock Information
- Founded
- RVNC 1999
- XFLT 2017
- Country
- RVNC United States
- XFLT United States
- Employees
- RVNC N/A
- XFLT N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- XFLT Investment Managers
- Sector
- RVNC Health Care
- XFLT Finance
- Exchange
- RVNC Nasdaq
- XFLT Nasdaq
- Market Cap
- RVNC 320.5M
- XFLT 380.6M
- IPO Year
- RVNC 2014
- XFLT N/A
- Fundamental
- Price
- RVNC $3.09
- XFLT $6.62
- Analyst Decision
- RVNC Hold
- XFLT
- Analyst Count
- RVNC 9
- XFLT 0
- Target Price
- RVNC $8.45
- XFLT N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- XFLT 336.2K
- Earning Date
- RVNC 11-07-2024
- XFLT 01-01-0001
- Dividend Yield
- RVNC N/A
- XFLT 14.17%
- EPS Growth
- RVNC N/A
- XFLT N/A
- EPS
- RVNC N/A
- XFLT N/A
- Revenue
- RVNC $256,945,000.00
- XFLT N/A
- Revenue This Year
- RVNC $11.28
- XFLT N/A
- Revenue Next Year
- RVNC $27.21
- XFLT N/A
- P/E Ratio
- RVNC N/A
- XFLT N/A
- Revenue Growth
- RVNC 25.82
- XFLT N/A
- 52 Week Low
- RVNC $2.30
- XFLT $6.01
- 52 Week High
- RVNC $9.75
- XFLT $7.76
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- XFLT 41.49
- Support Level
- RVNC $3.06
- XFLT $6.29
- Resistance Level
- RVNC $3.09
- XFLT $6.84
- Average True Range (ATR)
- RVNC 0.11
- XFLT 0.12
- MACD
- RVNC 0.02
- XFLT -0.03
- Stochastic Oscillator
- RVNC 6.90
- XFLT 49.24
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which primarily invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.